
Persista Bio Secures Two NIH Grants to Advance O2Line™ Oxygenated Cell Therapy Platform
Funding supports large-animal studies and clinical-grade manufacturing of novel systems designed to overcome oxygenation and fibrosis barriers in cell therapy. ITHACA, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- Persista Bio®, …